top of page

PELAFORCE™ pelargonium sidoides Now Safe for Children Under 3!

Empowering Families with Safe and Natural Solutions: PELAFORCE™ pelargonium sidoides active ingredient - Now Approved for Children Under 3!


At Afraceuticals, we are committed to providing safe and effective natural remedies for the entire family. Today, we are thrilled to share some exciting news regarding the safety and efficacy of PELAFORCE™, especially for the youngest members of the family! We are pleased to announce that a series of studies have confirmed that Pelargonium sidoides extract, the key ingredient in PELAFORCE™, is now deemed safe and effective for children as young as 1 year old.


Here are some of the key findings from recent research:


1. Safety of Pelargonium Extract EPs 7630 in Young Children with Acute Bronchitis

This recent groundbreaking study investigated the safety and tolerability of EPs 7630 syrup and oral solution in children aged 1–5 years with acute bronchitis. The findings revealed that both pharmaceutical forms, syrup and oral solution, were equally safe and well tolerated in pre-school children. Importantly, more than 90% of children experienced an improvement in symptoms, and parents were highly satisfied with the treatment.




2. Effectiveness of Pelargonium sidoides in Pediatric Patients Diagnosed with Uncomplicated Upper Respiratory Tract Infection

Another study explored the effectiveness of Pelargonium sidoides root extract in improving symptoms of uncomplicated upper respiratory tract infections (URTI) in paediatric patients. The results demonstrated that patients treated with Pelargonium sidoides root extract showed significant symptom improvement compared to the placebo group. This natural remedy proved effective in relieving symptoms such as dry cough, sneezing, and reducing cough frequency.




3. Pelargonium sidoides extract EPs 7630: a review of its clinical efficacy and safety for treating acute respiratory tract infections in children


This is a comprehensive review focused on the clinical efficacy and safety of EPs 7630 in children and adolescents with various acute respiratory tract infections (aRTI). The review found that EPs 7630 was effective in alleviating aRTI symptom severity, particularly in asthmatic children. Importantly, all reviewed studies reported good safety and tolerability of EPs 7630, reassuring parents and caregivers.




4. Pelargonium Sidoides for Pediatric Bronchitis

The use of EPs 7630 in children and adolescents with acute bronchitis was investigated in this study. Treatment was dosed at 10 drops 3 times daily for ages 1–6, 20 drops 3 times daily for ages 6–12, and 30 drops 3 times daily for ages 12–18, with significant reductions in bronchitis-specific symptoms observed. EPs 7630 was well tolerated, and patients in the treatment group reported higher satisfaction with the treatment.




These research findings provide compelling evidence that PELAFORCE™ is not only safe but also effective for children as young as 1 year old. We are proud to offer a natural remedy that parents can trust to alleviate the discomfort associated with respiratory tract infections in their little ones.


Stay tuned for more updates and exciting developments at Afraceuticals as we continue our mission to provide safe and effective natural remedies for the wellbeing of the whole family.



Recent Posts

See All

Comments


bottom of page